ETC
CERE

Exchange Traded Concepts’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Exchange Traded Concepts’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-156
Closed -$6.38K – 1458
2024
Q2 		$6.38K Buy
156
+56
+56% +$2.33K ﹤0.01% 1153
2024
Q1 		$4.23K Buy
+100
New +$4.2K ﹤0.01% 1193

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Exchange Traded Concepts's CERE Position: Q3 2024 in Review

Exchange Traded Concepts sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 156 shares — an estimated $6.38K sold.

Exchange Traded Concepts first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $6.38K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Exchange Traded Concepts reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Exchange Traded Concepts sold 156 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $6.38K.
  • Exchange Traded Concepts first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Exchange Traded Concepts's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $6.38K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Exchange Traded Concepts's 13F filing for Q3 2024, filed 10 Oct 2024.